| Erscheinungsdatum | Titel | Autor(en) |
121 | 2021 | Experimental evaluation of nickel and cobalt release from tools and self-reported prevalence of nickel and cobalt allergy in the German hairdressing trade | Symanzik, C.; Skudlik, C. ; John, S. M. |
122 | 2021 | Treatment with alitretinoin in patients taking part in a tertiary individual prevention program for work-related skin diseases | Obermeyer, Lara; Skudlik, Christoph ; John, Swen M. ; Brans, Richard |
123 | 2021 | Sensitization to 1,3-diphenylguanidine: An underestimated problem in physicians and nurses using surgical gloves? | Hansen, Andreas; Buse, Anna-Sophie; Wilke, Annika; Skudlik, Christoph ; John, Swen M. ; Brans, Richard |
124 | 2021 | Assessment of the effects of a work-related allergy to seafood on the reduction of earning capacity in the context of BK No. 5101. | Dickel, Heinrich ; Kuehn, Annette; Dickel, Beate; Bauer, Andrea; Becker, Detlef; Fartasch, Manigé; Haeberle, Michael; John, Swen Malte ; Mahler, Vera; Skudlik, Christoph ; Weisshaar, Elke; Werfel, Thomas; Geier, Johannes; Diepgen, Thomas L. |
125 | 2022 | Prevention of occupational hand eczema in healthcare workers during the COVID-19 pandemic: A controlled intervention study | Symanzik, Cara; Stasielowicz, Lukasz; Brans, Richard ; Skudlik, Christoph ; John, Swen Malte |
126 | 2022 | Acceptance of skin products in healthcare workers: an empirical investigation | Symanzik, C.; Skudlik, C. ; John, S. M. |
127 | 2022 | Indication and Reimbursement of Costs for Biologics in professional Association Treatment by using the example of Dupilumab: A Basis for Discussion | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St; Skudlik, C. ; John, S. M. |
128 | 2022 | Recommendation: Indication and cost coverage for biologics within therapies of the employer's liability insurance association by the example of Dupilumab: a basis for discussion | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St; Skudlik, C. ; John, S. M. |
129 | 2022 | Novel systemic medications-especially for treatment of atopic dermatitis-within therapies of the employer?s liability insur- ance association-a basis for discussion | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, S.; Skudlik, C. ; John, S. M. |
130 | 2022 | Systematic analysis of patient-specific substance testing in Germany: DGUV research project FB 317b on quality assurance in the diagnosis of occupational type IV allergies | Symanzik, C.; Dicke, K.; Brans, R. ; Weinert, P.; Skudlik, C. ; John, S. M. |
131 | 2022 | Nickel and cobalt release from beauty tools: A field study in the German cosmetics trade | Symanzik, Cara; Uter, Wolfgang; Becker, Selina-Marie; Skudlik, Christoph ; John, Swen M. |
132 | 2022 | Bleaching powders, bleaching creams and other hair lightening preparations as sources for (airborne) allergic contact dermatitis and other health effects in hairdressers: Results of an empirical study | Symanzik, Cara; Koopmann, Kirsten; Skudlik, Christoph ; John, Swen M. ; Uter, Wolfgang |
133 | 2022 | Effects of skin washing frequency on the epidermal barrier function and inflammatory processes of the epidermis: An experimental study | Symanzik, Cara; Kezic, Sanja; Jakasa, Ivone; Skudlik, Christoph ; John, Swen Malte ; Brans, Richard ; Sonsmann, Flora Karla |
134 | 2022 | Adverse skin reactions caused by masks in healthcare workers during the COVID-19 pandemic: an empirical investigation in a Lower Saxonian maximum-care hospital | Symanzik, C.; Koerbel-Peceny, C.; Luettje, D.; Engelhardt, M.; Skudlik, C. ; John, S. M. |
135 | 2022 | What do COVID-19-associated hygiene measures mean for the skin health of healthcare workers? Results of a controlled, prospective intervention study | Symanzik, Cara; Stasielowicz, Lukasz; Brans, Richard ; Skudlik, Christoph ; John, Swen Malte |
136 | 2022 | Recommendation: Indication and cost coverage for biologics within therapies of the employer's liability insurance association by the example of Dupilumab: A basis for discussion [Indikation und Kostenübernahme von Biologika im berufsgenossenschaftlichen Heilverfahren am Beispiel von Dupilumab: Eine Diskussionsgrundlage] | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St.; Skudlik, C. ; John, S.M. |
137 | 2022 | Systematic Analysis of the Testing of Patients' own Substances in Germany: DGUV Research Project FB 317b for Quality Assurance in the Diagnosis of occupational type IV Allergies | Symanzik, C.; Dicke, K.; Brans, R. ; Weinert, P.; Skudlik, C. ; John, S. M. |
138 | 2022 | Guidelines for diagnosis, prevention, and treatment of hand eczema | Thyssen, Jacob P.; Schuttelaar, Marie L. A.; Alfonso, Jose H.; Andersen, Klaus E.; Angelova-Fischer, Irena; Arents, Bernd W. M.; Bauer, Andrea; Brans, Richard ; Cannavo, Alicia; Christoffers, Wianda A.; Crepy, Marie-Noelle; Elsner, Peter; Fartasch, Manige; Filon, Francesca Larese; Gimenez-Arnau, Ana M.; Goncalo, Margarida; Guzman-Perera, Maria G.; Hamann, Carsten R.; Hoetzenecker, Wolfram; Johansen, Jeanne Duus; John, Swen M. ; Kunkeler, Amalia C. M.; Hadzavdic, Suzana Ljubojevic; Molin, Sonja; Nixon, Rosemary; Oosterhaven, Jart A. F.; Rustemeyer, Thomas; Serra-Baldrich, Esther; Shah, Mili; Simon, Dagmar; Skudlik, Christoph ; Spiewak, Radoslaw; Valiukeviciene, Skaidra; Voorberg, Angelique N.; Weisshaar, Elke; Agner, Tove |
139 | 2023 | Hand eczema and statutory accident insurance-what you should know for your practice | John, Swen Malte ; Symanzik, Cara; Skudlik, Christoph |
140 | 2023 | Implementation and evaluation of an e-learning training concept for the imple- mentation of the German occupational dis- eases legal changes regarding the occupa- tional disease number 5101 | Symanzik, C.; Altenburg, C.; Awe, S.; Palsherm, K.; Marx, M.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, S.; Skudlik, C. ; John, S. M. |